EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Role of miRNA‑214‑3p in cancer (Review)

Zeshan Chen, Xin Deng, Yuanhong Lu, Ling Lu, Yijue Qin, Haishun Qu, Shaohang Lan

Oncology Reports · 2025

DOI: 10.3892/or.2025.8957 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Oncology Reports, 2025. Verfasst von Zeshan Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, Guangxi Zhuang Autonomous Region People's Hospital, Nanning, Guangxi 530016, P.R. China. Hauptthemen laut MEDLINE: MicroRNAs, Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

microRNA‑214‑3p (miRNA‑214‑3p) can be mapped to the human chromosome 1q24.3 and is ~22 nucleotides in length. It has been garnering considerable attention due to its aberrant expression profile in various different types of cancer and its apparent role in regulating tumor progression. In malignant tumors, miRNA‑214‑3p can serve as a tumor suppressor or oncogene. This can be mediated by mainly inhibiting the expression of target genes by binding to the 3'‑untranslated region of target mRNAs, thereby regulating multiple downstream cellular processes, such as cell proliferation, metastasis, invasion and apoptosis. However, the role of miRNA‑214‑3p in cancer remains unclear. Therefore, in the present review, the role of miRNA‑214‑3p in cancer was summarized, whilst analyzing its potential as a biomarker for cancer diagnosis, prognosis and response to treatment. In addition, the present review evaluates its effects on sensitivity to chemotherapy, targeted therapy and radiotherapy. The current proposed strategies for the systemic delivery of miRNA‑214‑3p in cancer were also discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsNeoplasmsBiomarkers, TumorHumansGene Expression Regulation, NeoplasticPrognosisCell ProliferationApoptosis

Stichwörter der Autor:innen

biomarkercancer; diagnosismicroRNA‑214‑3pprognosis

Substanzen

MicroRNAsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Traditional Chinese Medicine, Guangxi Zhuang Autonomous Region People's Hospital, Nanning, Guangxi 530016, P.R. China.
  • School of Basic Medical Sciences, Guangxi University of Traditional Chinese Medicine, Nanning, Guangxi 530200, P.R. China.

Zitieren

APA

Chen, Z., Deng, X., Lu, Y., Lu, L., Qin, Y., Qu, H., & Lan, S. (2025). Role of miRNA‑214‑3p in cancer (Review). Oncology Reports. https://doi.org/10.3892/or.2025.8957

Vancouver

Chen Z, Deng X, Lu Y, Lu L, Qin Y, Qu H, et al. Role of miRNA‑214‑3p in cancer (Review). Oncology Reports. 2025. doi:10.3892/or.2025.8957

BibTeX
@article{Chen2025,
  author = {Chen, Zeshan and Deng, Xin and Lu, Yuanhong and Lu, Ling and Qin, Yijue and Qu, Haishun and Lan, Shaohang},
  title = {Role of miRNA‑214‑3p in cancer (Review)},
  journal = {Oncology Reports},
  year = {2025},
  doi = {10.3892/or.2025.8957}
}
Kostenlos starten →